4th Quarter - Report

THE DUBERSTEIN GROUP INC. for GILEAD SCIENCES, INC.

Firm
Client
Income
$90,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Issues related to COVID-19: H.R.133 - Consolidated Appropriations Act, 2021; Implementation Delay of 2021 NBPP Rule

LobbyistCovered position, as disclosed
BRIAN GRIFFIN —

Contacted: SENATE

Bills named: H.R. 133 (116th)

Budget/Appropriations BUD

Issues related to COVID-19: H.R.133 - Consolidated Appropriations Act, 2021 Omnibus Appropriations: H.R.133 - Consolidated Appropriations Act, 2021

LobbyistCovered position, as disclosed
DAVID J SCHIAPPA —

Contacted: SENATE

Bills named: H.R. 133 (116th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.